Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 5, 2003, Pages 826-830

  Pereira Chioccola, Vera Lucia ^a   Fragata Filho, Abilio Augusto ^b   De Apparecida Levy, Antonio Marcos ^b   Rodrigues, Mauricio M ^c   Schenkman, Sergio ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BENZNIDAZOLE; IMMUNOGLOBULIN; RECOMBINANT ENZYME; SIALIDASE;

ADULT; ANTIBODY TITER; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC VALUE; DISEASE CONTROL; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT MONITORING; PERSISTENT INFECTION; PRIORITY JOURNAL; SERUM; TRYPANOSOMA CRUZI; VISCERAL LEISHMANIASIS;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; LEISHMANIASIS; NEURAMINIDASE; NITROIMIDAZOLES; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TRYPANOCIDAL AGENTS;

EID: 0141675203     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.5.826-830.2003     Document Type: Article

References (31)

1. Almeida, I. C., D. T. Covas, L. M. Soussumi, and L. R. Travassos. 1993. A highly sensitive and specific chemilumincscent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37:850-857.
2. Almeida, I. C., G. M. Krautz, A. U. Krettli, and L. R. Travassos. 1993. Glycoconjugates of Trypanosoma cruzi: a 74 HD antigen of trypomastigotes specifically reacts with lytic anti-α-galactosyl antibodies from patients with chronic Chagas disease. J. Clin. Lab. Anal. 7:307-316.
3. Buchovsky, A. S., O. Campetella, G. Russomando, L. Franco, R. Oddone, N. Candia, A. Luquetti, S. M. Gonzalez Cappa, and M. S. Leguizamon. 2001. trans-Sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Clin. Diagn. Lab. Immunol. 8:187-189.
4. Camargo, M. E. 1966. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev. Inst. Med. Trop. Sao Paulo 8:227-235.
5. Camargo, M. E., S. Hoshino, and G. R. Siqueira. 1973. Hemagglutination with preserved, sensitized cells, a practical test for routine serologic diagnosis of American trypanosomiasis. Rev. Inst. Med. Trop. Sao Paulo 15:81-85.
6. Costa, F., M. Ribeirão, V. L. Pereira-Chioccola, S. Schenkman, and M. M. Rodrigues. 1999. trans-Sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection. Braz. J. Med. Biol. Res. 32:235-239.
7. Da Silveira, J. F., E. S. Umezawa, and A. O. Luquetti. 2001. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol. 17:286-291.
8. Dias, J. C. P. 1992. Epidemiology of Chagas' disease, p. 49-80. In S. Wendel, Z. Brener, M. E. Camargo, and A. Rassi (ed.), Chagas' disease (American trypanosomiase): its impact on transfusion and clinical medicine - 1992. ISPT, São Paulo, Brazil.
9. Fragata Filho, A. A., M. A. da Silva, and E. Boainain. 1995. Etiologic treatment of acute and chronic Chagas' disease. Rev. Paul Med. 113:867-872.
10. Frasch, A. C. 2000. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 16:282-286.
11. Galvão, L. M., R. M. Nunes, J. R. Cançado, Z. Brener, and A. U. Krettli. 1993. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans. R. Soc. Trop. Med. Hyg. 87:220-223.
12. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
13. Krettli, A. U., and L. Pontes de Carvalho. 1986. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade. Clin. Exp. Immunol. 62:270-277.
14. Leguizamon, M. S., O. Campetella, G. Russomando, M. Almiron, I. Guillen, S. M. Ganzalez Cappa, and A. C. Frasch. 1994. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J. Infect. Dis. 170:1570-1574.
15. Leguizamon, M. S., G. Russomando, A. Luquetti, A. Rassi, M. Almiron, S. M. Gonzalez-Cappa, A. C. Frasch, and O. Campetella. 1997. Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured Chagasic patients. J. Infect. Dis. 175:1272-1275.
16. Leguizamon, M. S., G. Russomando, D. A. Rojas, M. Samudio, M. Cabral, S. M. Gonzalez-Cappa, A. C. Frasch, and O. Campetella. 1998. Use of trans-sialidase inhibition assay in a population serologically negative for Trypanosoma cruzi but at a high risk of infection. Clin. Diagn. Lab. Immunol. 5:254-255.
17. Levy, A. M., E. Bainain, and J. K. Kloetzel. 1996. In situ indirect fluorescent antibody: a new specific test to detect ongoing Chagasic infections. J. Clin. Lab. Anal. 10:98-103.
18. Malchiodi, E. L., M. G. Chiaramonte, N. J. Taranto, N. W. Zwirner, and R. A. Margni. 1994. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6). Clin. Exp. Immunol. 97:417-423.
19. Martins, O. A., M. E. S. Pereira, J. F. Carvalho, J. R. Cancado, and Z. Brener. 1995. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease. Clin. Diagn. Lab. Immunol. 2:569-573.
20. Moncayo, A. 1992. Chagas' disease: epidemiology and prospects for interruption of transmission in the Americas. World Health Stat. Q. 45:276-279.
21. Norris, K. A. 1998. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 66:2460-2465.
22. Pereira, V. L., A. M. Levy, and E. Boainain. 1989. Xenodiagnosis, hemoculture and the complement mediated lysis test, as criteria in selecting chronic chagasic patients for chemotherapy. Rev. Inst. Med. Trop. Sao Paulo 31:301-307. (In Portuguese.)
23. Pereira-Chioccola, V. L., F. Costa, M. Ribeirão, I. S. Soares, F. Arena, S. Schenkman, and M. M. Rodrigues. 1999. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite gene delivered as naked DNA or recombinant protein. Parasite Immunol. 21:103-110.
24. Pereira-Chioccola, V. L., S. Schenkman, and J. Kloetzel. 1994. Sera from chronic Chagasic patients and animals infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its catalytic domain. Infect. Immun. 62:2973-2978.
25. Ribeirão, M., V. L. Pereira-Chioccola, D. Eichinger, M. M. Rodrigues, and S. Schenkman. 1997. Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology 7:1237-1246.
26. Ribeirão, M., V. L. Pereira-Chioccola, L. Renia, A. A. Fragata-Filho, S. Schenkman, and M. M. Rodrigues. 2000. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 22:49-53.
27. Rodrigues, M. M., M. Ribeirão, V. L. Pereira-Chioccola, L. Renia, and F. Costa. 1999. Predominance of CD4 Th1 and CD8 TC1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67:3855-3863.
28. Schenkman, S., D. Eichinger, M. E. A. Pereira, and V. Nussenzweig. 1994. Structural and functional properties of Trypanosoma cruzi trans-sialidase. Annu. Rev. Microbiol. 48:499-523.
29. Umezawa, E. S., M. S. Nascimento, N. Kesper, Jr., J. R. Coura, J. Borges-Pereira, A. C. Junqueira, and M. E. Camargo. 1996. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J. Clin. Microbiol. 34:2143-2147.
30. Umezawa, E. S., M. A. Shikanai-Yasuda, A. Gruber, V. L. Pereira-Chioccola, and B. Zingales. 1996. Trypanosoma cruzi defined antigens in the serological evaluation of an outbreak of acute Chagas' disease in Brazil (Catole do Rocha, Paraiba). Mem. Inst. Oswaldo Cruz 91:87-93.
31. World Health Organization. 1995. Chagas' disease: important advances in elimination of transmission in four countries in Latin America. WHO Feature 183:1-3.